Łukasz Galus

Vitamin D supplementation increases objective response rate and prolongs progression‐free time in patients with advanced melanoma undergoing anti–PD‐1 therapy

Łukasz Galus, Michał Michalak, Mateusz Lorenz et al. · Cancer · 2023 · 47 citations · Full text

Medicine, Immunology, Oncology +17

A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition

Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik‐Schmidt et al. · Cancers · 2022 · 28 citations · Full text

Life Sciences, Microbiology, Oncology +17

The Analysis of Inflammation-Related Proteins in a Cargo of Exosomes Derived from the Serum of Uveal Melanoma Patients Reveals Potential Biomarkers of Disease Progression

Joanna Wróblewska, Michał Lach, Katarzyna Kulcenty et al. · Cancers · 2021 · 24 citations · Full text

Medicine, Immunology, Oncology +17

BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma

Bożena Cybulska-Stopa, Paweł Rogala, Anna M. Czarnecka et al. · Melanoma Research · 2020 · 21 citations

Medicine, Oncology, Pharmacotherapy +15

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy

Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus et al. · Cells · 2023 · 21 citations · Full text

Medicine, Immunology, Oncology +16